Omnicell, Inc. (OMCL) Market Cap & Valuation Ratios
Omnicell, Inc. (OMCL) has a market cap of $1.7B and a price-to-sales ratio of 1.4, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
OMCLOmnicell, Inc.Follow OMCL — free
—
Price chart with a free account
- Market cap
- 1.7B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
Peers
health information services · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| OMCL | 1.7 | — | 1.3 | 11.9 | 7.4% | +8% | 5% | 3% |
| HTFL | 4.9 | — | 22.5 | — | -1.2% | +43% | -38% | -33% |
| PRVA | 2.9 | 106.7 | 1.0 | 43.0 | 4.6% | +24% | 2% | 8% |
| CERT | 1.6 | — | 4.1 | 22.3 | 3.5% | +0.7% | -0.2% | -0.1% |
| OMDA | 1.2 | — | 3.0 | 172.8 | 1.5% | +48% | -0.1% | -1% |
| TDOC | 1.2 | — | 0.6 | 7.7 | 11.4% | -2% | -8% | -11% |
| HSTM | 1.0 | 48.8 | 3.0 | 13.7 | 4.0% | +9% | 8% | 7% |
| PHR | 0.8 | 74.7 | 1.5 | 15.7 | 8.6% | +13% | 2% | 3% |
| SDGR | 0.6 | — | 0.7 | — | — | +9% | -59% | -187% |
| WEAV | 0.6 | — | 2.1 | — | 1.9% | +17% | -8% | -60% |
| EVH | 0.5 | — | 0.7 | — | 4.5% | -5% | -20% | -33% |
| Median of these 10 | 74.7 | 1.8 | 19.0 | 4.0% | +11% | -4% | -6% |
; EV/Sales 1.3 vs. 1.8.
Growth vs. price
each dot a company · hover or tap for valuesOMCL and HTFL and CERT and OMDA and TDOC and SDGR and WEAV and EVH have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
Omnicell, Inc. — questions
- What is Omnicell, Inc.'s market cap?
- $1.7B.
- What is Omnicell, Inc.'s price-to-sales ratio?
- 1.4.
Every figure on this page comes from Omnicell, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.